Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$37.00
-0.22-0.59%
Pre-Market: 6:43 AM EDT
Comments
Loading...
BridgeBio Pharma (BBIO) Forecast
NewsEarningsBridgeBio Pharma (BBIO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
BridgeBio Pharma Stock Price, Quotes and Forecasts | NASDAQ:BBIO | Benzinga
Explore BridgeBio Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBIO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BridgeBio Pharma (BBIO) stock?
You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.
Who are BridgeBio Pharma (BBIO) competitors?
Other companies in BridgeBio Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?
BridgeBio Pharma has a consensus price target of $46.33.
What is the current price for BridgeBio Pharma (BBIO)?
The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $37 last updated March 25, 2025 at 6:43 AM EDT.
Does BridgeBio Pharma (BBIO) pay a dividend?
There are no upcoming dividends for BridgeBio Pharma.
When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?
BridgeBio Pharma’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is BridgeBio Pharma (BBIO) going to split?
There is no upcoming split for BridgeBio Pharma.
What sector and industry does BridgeBio Pharma (BBIO) operate in?
BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.